16 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines.

Glaxosmithkline
Pyrazole-based factor Xa inhibitors containing N-arylpiperidinyl P4 residues.

Bristol-Myers Squibb
The discovery and preparation of disubstituted novel amino-aryl-piperidine-based renin inhibitors.

Pfizer
Structural basis for inhibition promiscuity of dual specific thrombin and factor Xa blood coagulation inhibitors.

Boehringer Ingelheim Pharma
Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.

The Institute For Diabetes Discovery
A highly selective, non-hydantoin, non-carboxylic acid inhibitor of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3-methylbenzofuran- 2-sulfonyl)-2-H-pyridazin-3-one.

Pfizer
Structural and thermodynamic studies of simple aldose reductase-inhibitor complexes.

Medical College of Wiscosin
Evidence for a novel binding site conformer of aldose reductase in ligand-bound state.

University of Marburg
Structural and thermodynamic study on aldose reductase: nitro-substituted inhibitors with strong enthalpic binding contribution.

University of Marburg
Rapid Evolution of 6-Phenylpurine Inhibitors of Protein Kinase B through Structure-Based Design.

Astex
Identification of Inhibitors of Protein Kinase B Using Fragment-Based Lead Discovery.

Astex